Improving how intensive care units use evidence-based treatments for patients with respiratory failure
Organizational strategies for improving evidence-uptake in intensive care
This study looks at how ICU teams work together and make decisions to help ensure that patients with serious breathing problems get the best treatments based on the latest medical research.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10987021 on NIH RePORTER |
What this research studies
This research investigates how the organization and behavior of intensive care unit (ICU) teams affect the use of evidence-based treatments for patients suffering from acute respiratory failure. By examining the interactions among ICU team members, the study aims to identify barriers and facilitators to implementing proven medical practices. The research will develop new methods to measure ICU performance, explore the role of team dynamics in decision-making, and enhance decision support tools like checklists to improve patient care. Ultimately, the goal is to ensure that critically ill patients receive the best possible treatments based on the latest evidence.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients in intensive care units who are experiencing acute respiratory failure and require mechanical ventilation.
Not a fit: Patients who are not in critical care or do not have acute respiratory failure may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved patient outcomes by ensuring that critically ill patients receive timely and effective evidence-based treatments.
How similar studies have performed: Previous research has shown that improving organizational strategies in healthcare settings can enhance the uptake of evidence-based practices, suggesting a promising avenue for this study.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Kahn, Jeremy M — University of Pittsburgh at Pittsburgh
- Study coordinator: Kahn, Jeremy M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.